Echo Therapeutics Schedules First Quarter 2014 Financial Results and Regulatory and Product Development Update for Friday, May 9, 2014

[PR Newswire] – PHILADELPHIA, May 8, 2014 /PRNewswire/ — Echo Therapeutics, Inc. (ECTE), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it will release more

View todays social media effects on ECTE

View the latest stocks trending across Twitter. Click to view dashboard

See who Echo is hiring next, click here to view